Steven Cohen's KYTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 222,929 shares of Kyverna Therapeutics, Inc. (KYTX) worth $1.92 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Steven Cohen has maintained this position in KYTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 190,745 shares. Largest reduction occurred in Q4 2024, reducing 34,482 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Kyverna Therapeutics (KYTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kyverna Therapeutics (KYTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +190,745 | Add 592.67% | 222,929 | $8.63 |
| Q4 2025 | +5,008 | Add 18.43% | 32,184 | $9.40 |
| Q3 2025 | -28,346 | Reduce 51.05% | 27,176 | $6.00 |
| Q2 2025 | +55,522 | New Buy | 55,522 | $3.07 |
| Q4 2024 | -34,482 | Sold Out | 0 | $0.00 |
| Q3 2024 | +34,482 | New Buy | 34,482 | $4.89 |
| Q2 2024 | -20,900 | Sold Out | 0 | $0.00 |
| Q1 2024 | +20,900 | New Buy | 20,900 | $24.84 |
Steven Cohen's Kyverna Therapeutics Investment FAQs
Steven Cohen first purchased Kyverna Therapeutics, Inc. (KYTX) in Q1 2024, acquiring 20,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Kyverna Therapeutics, Inc. (KYTX) for 8 quarters since Q1 2024.
Steven Cohen's largest addition to Kyverna Therapeutics, Inc. (KYTX) was in Q1 2026, adding 222,929 shares worth $1.92 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 222,929 shares of Kyverna Therapeutics, Inc. (KYTX), valued at approximately $1.92 M.
As of the Q1 2026 filing, Kyverna Therapeutics, Inc. (KYTX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Kyverna Therapeutics, Inc. (KYTX) was 222,929 shares, as reported at the end of Q1 2026.